Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing desonide in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desonide (substance) |
Inferred relationship |
Some |
|
Product containing desonide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely desonide 500 microgram/1 milliliter conventional release ear solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desonide (substance) |
Inferred relationship |
Some |
|
Desonide 500 microgram/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desonide (substance) |
Inferred relationship |
Some |
|
Product containing precisely desonide 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desonide (substance) |
Inferred relationship |
Some |
|
Desonide 500 microgram/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desonide (substance) |
Inferred relationship |
Some |
|
Tridesilon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desonide (substance) |
Inferred relationship |
Some |
|
Desonide adverse reaction |
Causative agent (attribute) |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |
Allergy to desonide |
Causative agent (attribute) |
False |
Desonide (substance) |
Inferred relationship |
Some |
|
Desonide 500 microgram/mL cutaneous foam |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desonide (substance) |
Inferred relationship |
Some |
|
Desonide 500 microgram/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Desonide (substance) |
Inferred relationship |
Some |
|
Desonide-containing product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |
Allergy to desonide |
Causative agent (attribute) |
False |
Desonide (substance) |
Inferred relationship |
Some |
2 |
Allergy to desonide |
Causative agent (attribute) |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |
Product containing desonide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |
Product containing only desonide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |
Product containing only desonide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |
Product containing only desonide in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |
Desonide 500 microgram/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |
Desonide 500 microgram/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |
Desonide 500 microgram/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |
Desonide 500 microgram/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely desonide 500 microgram/1 milliliter conventional release ear solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely desonide 500 microgram/1 milliliter conventional release ear solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |
Desonide 500 microgram/mL cutaneous foam |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |
Desonide 500 microgram/mL cutaneous foam |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely desonide 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely desonide 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |
Desonide 500 microgram/mL cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |
Desonide 500 microgram/mL cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Desonide (substance) |
Inferred relationship |
Some |
1 |